Impacting on the mental and physical symptoms of IBS patients with guided imagination technique
Abstract
INTRODUCTION: Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain interaction defined by digestive symptoms, affecting 1 in 10-15 people worldwide. The incidence of IBS in Hungary is currently 15-20%, with a constantly increasing trend. Functional bowel disease is physically characterized by recurrent bloating, abdominal pain and/or changes in the frequency and consistency of stool. Studies also reveal that IBS patients have a 35% higher level of anxiety and depression compared to healthy controls. Further research found that the presence of sleep disorder as a characteristic stressor was significantly associated with IBS. According to several studies, psychotherapies targeting the nervous and intestinal system, such as hypnosis, have a long-term positive effect on IBS symptoms. The present study discusses the extent to which direct suggestions affecting the nervous system via guided imagination technique for digestion can affect the typical physical and mental symptoms of the IBS target group.
METHODOLOGY: The adult participants of our study enrolled via Facebook. The input questionnaire we sent to them included two main groups of questions, one of which measured their level of depression on the internationally noted Beck depression scale, and the other assessing the presence and severity of their physical digestive symptoms determined by the Rome IV diagnostic criteria of IBS. The guided visualization audio material was made based on the NERVA application developed by Monash University, Australia. These 10-13-minute daily audio recordings were sent to the 41 participants every morning for six weeks. At the end of the six weeks 28 of them returned the output status assessment questionnaire to us completed. By summing up their answers, we carried out statistical analysis in order to determine the general improvement of mental and physical symptoms, and also in scope of the frequency of listening to the guided imagination audio material.
RESULTS: In summary, the results showed that the most significant improvement occurred in the level of anxiety. Additionally, both the severity of abdominal pain symptoms and abdominal bloating decreased among the 28 participants. Sleep disorders also showed significant improvement in the output measures. Regarding the frequency of listening to the audio material effecting the improvement of symptoms, we found a significant correlation only concerning the level of depression.
CONCLUSIONS: We can say that by listening to the 6-week imagination audio material, both depression and sleep disorders, which have been shown to be closely related, can be significantly reduced in IBS patients, as well as the strength of their symptoms of bloating, lower abdominal pain, and anxiety. Regarding the frequency of listening, the conclusion can be drawn that if the guided visualization audio is listened to at least every days, a more significant improvement in the level of depression can be achieved than in those who listen to the daily sent audio less often.
References
Bonaz, B., Bazin, T., Pellissier, S. (2018). The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Fron-tiers in Neuroscience, Vol. 12, doi: 10.3389/fnins.2018.00049
Buono, J.L., Carson, R.T., Flores, N.M. (2017). Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhoea. Health and Quality of Life Outcomes, Vol. 15, No. 35, doi: 10.1186/s12955-017-0611-2
Cryan, J. F., O'Riordan, K.J., Cowan, C. S. M., Sandhu K. V., Thomaz F. S. B., Marcus B., Martin G. C., Sofia C., Christine F., Anna V. G., Katherine E. G., Minal J., Caitriona M. L-S., Joshua M. L., Jason A. M., Alicia M-P., Gerard M., Emanuela M., Enrique M. (2019). The Microbiota Gut-Brain Axis. Physiological Reviews, Vol. 99, No. 4, doi: 10.1152/physrev.00018.2018
Hu, Z., Li, M., Yao, L., Wang, Y., Wang, E., Yuan, J., Wang, F., Yang, K., Bian, Z., & Zhong, L. D. (2021). The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterology, 7;21(1):23. doi: 10.1186/s12876-020-01593-5
Kuo, B., Bhasin, M. Jacquart, J., Scult, M. A., Slipp, L., Riklin, E I. K., Lepoutre, V., Comosa, N., Norton, B-A., Dassatti, A., Rosenblum, J., Thurler, A. H., Surjanhata, B. C., Hasheminejad, N. N., Kagan, L., Slawsby, E., Rao, S.R., Macklin, E. A., Fricchione, G. L. (2017, febr. 21). Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease, PLoS ONE 10(4). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0172872
Lowén, M. B. O., Mayer, E. A., Sjöberg, M., Tillisch, K., Naliboff, B., Labus, J., Lundberg, P., Ström, M., Engström, M., Walter, S. A. (2013). Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, Vol. 37, Issue 12, pp. 1184-1197. doi: 10.1111/apt.12319
Long-Smith, C., O'Riordan, K J., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020). Microbiota-Gut-Brain Axis: New Therapeutic opportunities. Annual Review of Pharmacology and Toxicology, Vol. 60, pp. 477-502.
Mindset Health, NERVA, (2023). https://try.nervaibs.com/
Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacological Therapies, 44(5):447-59. doi: 10.1111/apt.13706
Polgár A., Szálka B., Molnár T., Kósa I., Vassányi I., Mák E. dr. (2022). A mobilapplikációval támogatott alacsony-FODMAP-étrend a funkcionális gastrointestinalis és a gyulladásos bélbetegségek kezelésében. Orvosi Hetilap, 163(31): 1224–1230. doi: 10.1556/650.2022.32502
Reutov, V. P., & Sorokina, E. G. (2022). Causal Relationship between Physiological and Pathological Processes in the Brain and in the Gastrointestinal Tract: The Brain–Intestine Axis. Biophysics, Vol. 67, pp. 972–986.
Roberts, L., Wilson, S., Singh, S., Roalfe, A., Greenfield, S. (2006). Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. British Journal of General Practice, Vol. 56, Issue 523, pp. 115-121.
Rome Foundation (2016). Rome IV Multidimensional Clinical Profile for Functional Gastrointestinal Disorders: MDCP (Second Edition) https://theromefoundation.org/rome-iv/rome-iv-criteria/
Rózsa, S., Szádóczky, E., & Füredi, J. (2001). A Beck depresszió kérdőív rövidített változatának jellemzői hazai mintán [Psychometric properties of the Hungarian version of the shortened Beck Depression Inventory]. Psychiatria Hungarica, 16(4), 384–402. Beck, Rövidített depresszió skála, https://maskepp.hu/tesztek/beck_depresszio_skala.doc
Spiegel, D. (2013). Transformations: Hypnosis in Brain and Body. Wiley Periodicals, Depression and Anxiety, 30:342–352.
Staudacher, H. M., Whelan, K. (2023. október 05). Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet, Cambridge University Press, https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/altered-gastrointestinal-microbiota-in-irritable-bowel-syndrome-and-its-modification-by-diet-probiotics-prebiotics-and-the-low-fodmap-diet/8A7E00D44BD17B2F192D8EEBE464AD03
Wang, B., Duan, R., & Duan, L. (2018). Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis. Saudi J Gastroenterol, May-Jun, 24(3): 141–150. doi: 10.4103/sjg.SJG_603_17
Whorwell P. J., Prior, A., Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of severe refrac-tory irritable-bowel syndrome. The Lancet, Dec 1;2(8414):1232-4. doi: 10.1016/s0140-6736(84)92793-4.
Zigmond, A.S., Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand, 67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x
